8:00 am Registration & Welcome Coffee
9:00 am Chair’s Opening Remarks
9:15 am Panel Discussion on Change Management when Implementing LAFM
Synopsis
- Implementing a LAFM program; what are the biggest barriers – infrastructure, cost, or mindset change?
- Building a business case that appeals to stakeholders, what are they looking for?
- Getting end users’ buy in: how to make it easy for scientists to help not hinder your LAFM plans?
10:00 am A New Solution for End-to-End Asset Management
Synopsis
- Software deployment for inventory and asset life’s tracking
- Servicing your asset and surplus equipment from OEMs and suppliers
- Monetization before it’s too late
10:30 am Speed Networking & Morning Refreshments
TRACK 1
Advancing Asset Management
TRACK 2
Progressing Facility Management
11:15 am Asset Utilization Beyond Surplus Equipment Identification
- Initial savings of asset utilization from removal of surplus equipment
- Looking beyond removal of surplus equipment, how to continue gaining ROI
- Using tracking of previous users, solvents, and processes to pinpoint reasons for equipment failures
- Redefining equipment best practices to reduce maintenance requirements and lean on peer-to-peer training
Linwood Bryant, Senior Manager, Asset Management, Regeneron
11:45 am Panel Discussion: Surplus Asset Management and
Disposition in Pharma
Nick Dove, President, Heritage Global Partners
Steven Planchon, Asset Lifecycle Manager, Pfizer
Senior Representative,Genentech
Biotech Solutions in Asset
Management.
.
12:15 pm Inventory Management: How Good Data is the Basis of Any Successful Program
- Ensuring your database is kept up to date
- How many resources/time to allocate building and maintaining master data?
- Cost detriment from “moved” equipment and working with end-users to maintain a current inventory
Gregg York, Facilities Operations, Translate Bio
12:45 pm Tracking Your Assets
- Ensuring your database is kept up to date
- How many resources/time to allocate building and maintaining master data?
- Cost detriment from “moved” equipment and working with end-users to maintain a current inventory
Diana Hage, CEO, RFID Global
11:15 am Integrated Facility Management Hybrid Model
- Retaining internal staff whilst onboarding IFM expertise
- What services to outsource and what works internally, contract management, staffscheduling etc.
- Case study one benefits brought to the business and TCO of this approach
Jedd Skibo, Director Global Category Procurement, Charles River Labs
Facility Management and Design in
Biotech.
.
11:45 am Don’t Go in Blind When Selecting New Lab Space; Key Design Considerations to Ease Installation Bottle Necks
- Importance of having a clear design, size and capacity in mind prior to site selection
- Planning for company growth in a sustainable fashion when selecting space
- Finding the right vendors to work with when looking for real estate
- When is best to rent or build from shell for your company
Annie Kang, Associate Director of Research Operations, Cue BioPharma
12:15 pm Making The First Move; From Incubator to Your Own Lab
- Prioritising task to get up and running an soon as possible, minimizing company downtime
- Sourcing vendors for the first time in the move out of rented space
- Optimizing your new space, removing surplus equipment and planning maintenance
Kevin Walsh, Senior Lab Manager, Guardian Therapeutics
12:45 pm Session Reserved for PHC Corporation
1:00 pm Networking Lunch
11:15 am Asset Utilization Beyond Surplus Equipment Identification
- Initial savings of asset utilization from removal of surplus equipment
- Looking beyond removal of surplus equipment, how to continue gaining ROI
- Using tracking of previous users, solvents, and processes to pinpoint reasons for equipment failures
- Redefining equipment best practices to reduce maintenance requirements and lean on peer-to-peer training
Linwood Bryant, Senior Manager, Asset Management, Regeneron
11:45 am Panel Discussion: Surplus Asset Management and
Disposition in Pharma
Nick Dove, President, Heritage Global Partners
Steven Planchon, Asset Lifecycle Manager, Pfizer
Senior Representative,Genentech
12:15 pm Inventory Management: How Good Data is the Basis of Any Successful Program
- Ensuring your database is kept up to date
- How many resources/time to allocate building and maintaining master data?
- Cost detriment from “moved” equipment and working with end-users to maintain a current inventory
Gregg York, Facilities Operations, Translate Bio
2:00 pm Lab Planning from an EHS perspective
- Retaining internal staff whilst onboarding IFM expertise
- What services to outsource and what works internally, contract management, staffscheduling etc.
- Case study one benefits brought to the business and TCO of this approach
Jedd Skibo, Director Global Category Procurement, Charles River Labs
11:45 am Don’t Go in Blind When Selecting New Lab Space; Key Design Considerations to Ease Installation Bottle Necks
- Importance of having a clear design, size and capacity in mind prior to site selection
- Planning for company growth in a sustainable fashion when selecting space
- Finding the right vendors to work with when looking for real estate
- When is best to rent or build from shell for your company
Annie Kang, Associate Director of Research Operations, Cue BioPharma
3:15 pm Afternoon Networking Tea
3:50 pm What are Integrated Lab Solutions?
Ensuring Compliance in Quality Controlled Labs
4:20 pm Equipment Periodic Review: A Business Case Applied in a QC Lab
Synopsis
- Improve performance of site equipment periodic review
- Seek opportunities to reduce costs and comply with quality policies
- Spread and level the workload for qualification activities
- Use CMMS to control periodic review activities
4:50 pm Harnessing the Power of Asset Utilization Data
Synopsis
- Scaling asset utilization monitoring to non-PC devices
- Lessons learned
- Same data, multiple insights (utilization, health, energy management)
- Customer case study (presented by customer)
5:20 pm GxP Equipment Validation
Synopsis
- Ensuring compliance for diagnostics and clinical labs
- Verify the confidence, integrity and traceability of data which are generated
- Establishing documented evidence that provides a high degree of assurance that a specific process will consistently produce a product that meets predetermined specifications and quality